Jonathan C. Fox

2.0k total citations
37 papers, 940 citations indexed

About

Jonathan C. Fox is a scholar working on Molecular Biology, Surgery and Cell Biology. According to data from OpenAlex, Jonathan C. Fox has authored 37 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 10 papers in Surgery and 7 papers in Cell Biology. Recurrent topics in Jonathan C. Fox's work include Fibroblast Growth Factor Research (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Parathyroid Disorders and Treatments (5 papers). Jonathan C. Fox is often cited by papers focused on Fibroblast Growth Factor Research (7 papers), Lipoproteins and Cardiovascular Health (6 papers) and Parathyroid Disorders and Treatments (5 papers). Jonathan C. Fox collaborates with scholars based in United States, Japan and Taiwan. Jonathan C. Fox's co-authors include Judith L. Swain, Paul M. Ridker, Gavin J. Blake, JoAnn E. Manson, Tetsuya Miyamoto, Herbert Schuster, Isabelle Leconte, Seiya Kato, David A. Tulis and David G. Neschis and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Circulation.

In The Last Decade

Jonathan C. Fox

36 papers receiving 917 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonathan C. Fox United States	18	446	326	182	121	120	37	940
Dalila Marques United States	17	359 0.8×	451 1.4×	87 0.5×	107 0.9×	122 1.0×	27	905
Cheryl S. Mueske United States	15	411 0.9×	273 0.8×	132 0.7×	196 1.6×	166 1.4×	16	979
Marcia Pessah France	17	678 1.5×	158 0.5×	112 0.6×	82 0.7×	77 0.6×	32	1.0k
Aruna Poduri United States	14	470 1.1×	201 0.6×	81 0.4×	199 1.6×	105 0.9×	17	953
Alykhan Motani United States	13	764 1.7×	293 0.9×	218 1.2×	295 2.4×	101 0.8×	18	1.5k
Chunjiang Fu China	15	555 1.2×	170 0.5×	277 1.5×	74 0.6×	55 0.5×	38	964
Barbara Salani Italy	16	547 1.2×	183 0.6×	211 1.2×	58 0.5×	190 1.6×	27	873
Yijiang Zhou China	16	247 0.6×	151 0.5×	106 0.6×	157 1.3×	46 0.4×	37	614
Shenaz Khan United States	16	536 1.2×	128 0.4×	112 0.6×	54 0.4×	94 0.8×	21	989

Countries citing papers authored by Jonathan C. Fox

Since Specialization

Citations

This map shows the geographic impact of Jonathan C. Fox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan C. Fox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan C. Fox more than expected).

Fields of papers citing papers by Jonathan C. Fox

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan C. Fox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan C. Fox. The network helps show where Jonathan C. Fox may publish in the future.

Co-authorship network of co-authors of Jonathan C. Fox

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan C. Fox. A scholar is included among the top collaborators of Jonathan C. Fox based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan C. Fox. Jonathan C. Fox is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Masri, Ahmad, Mandar A. Aras, Daniel Jacoby, et al.. (2025). Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up. Journal of Cardiac Failure. 31(8). 1354–1359. 2 indexed citations

Masri, Ahmad, Mandar A. Aras, Rodney H. Falk, et al.. (2024). Long-term Safety And Tolerability Of Acoramidis (AG10) In Symptomatic Transthyretin Amyloid Cardiomyopathy: 4-year Update From An Ongoing, Phase 2, Open-label Extension Study. Journal of Cardiac Failure. 30(1). 221–221. 3 indexed citations

Masri, Ahmad, Mandar A. Aras, Rodney H. Falk, et al.. (2022). LONG-TERM SAFETY AND TOLERABILITY OF ACORAMIDIS (AG10) IN SYMPTOMATIC TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: UPDATED ANALYSIS FROM AN ONGOING PHASE 2 OPEN-LABEL EXTENSION STUDY. Journal of the American College of Cardiology. 79(9). 227–227. 2 indexed citations

Roszko, Kelly L., Lyndsay Smith, Mary Scott Roberts, et al.. (2020). Autosomal Dominant Hypocalcemia Type 1: A Systematic Review. Journal of Bone and Mineral Research. 37(10). 1926–1935. 20 indexed citations

Devreese, Bart, Sahana Nagabhushan Kalburgi, Lavanya Bachaboina, et al.. (2013). Restoration of Cytoskeleton Homeostasis After Gigaxonin Gene Transfer for Giant Axonal Neuropathy. Human Gene Therapy. 24(2). 209–219. 36 indexed citations

Fox, Jonathan C., Santosh Sutradhar, Laura A. Demopoulos, et al.. (2004). The JNC 7 Approach Compared to Conventional Treatment in Diabetic Patients With Hypertension: A Double‐Blind Trial of Initial Monotherapy vs. Combination Therapy. Journal of Clinical Hypertension. 6(8). 437–442. 9 indexed citations

Schuster, Herbert & Jonathan C. Fox. (2004). Investigating cardiovascular risk reduction – the Rosuvastatin GALAXY Programme^™. Expert Opinion on Pharmacotherapy. 5(5). 1187–1200. 35 indexed citations

Sakata, Kiyohiko, Seiya Kato, Jonathan C. Fox, Minoru Shigemori, & Minoru Morimatsu. (2002). Autocrine Signaling through Ras Regulates Cell Survival Activity in Human Glioma Cells: Potential Cross-Talk between Ras and the Phosphatidylinositol 3-Kinase-Akt Pathway. Journal of Neuropathology & Experimental Neurology. 61(11). 975–983. 26 indexed citations

Blake, Gavin J., et al.. (2001). A prospective evaluation of lipoprotein-associated phospholipase A2levels and the risk of future cardiovascular events in women. Journal of the American College of Cardiology. 38(5). 1302–1306. 173 indexed citations

10.

Hunt, D. Margaret, et al.. (2001). Vitreous-induced Modulation of Integrins in Retinal Pigment Epithelial Cells: Effects of Fibroblast Growth Factor-2. Experimental Eye Research. 73(5). 681–692. 17 indexed citations

11.

Durán, Walter N., Isabelle Leconte, Jonathan C. Fox, et al.. (2000). Adenoviral-mediated expression of antisense RNA to basic fibroblast growth factor reduces tangential stress in arterialized vein grafts. Journal of Vascular Surgery. 31(4). 770–780. 7 indexed citations

12.

Kato, Seiya, Hideo Yasukawa, Miki Yamaguchi, et al.. (2000). Coordinate Regulation of Matrix Metalloproteinase-1 and Tissue Inhibitor of Metalloproteinase-1 Expression in Human Vascular Smooth Muscle Cells. Connective Tissue Research. 41(2). 143–153. 12 indexed citations

13.

Miyamoto, Tetsuya & Jonathan C. Fox. (2000). Autocrine Signaling through Ras Prevents Apoptosis in Vascular Smooth Muscle Cells in Vitro. Journal of Biological Chemistry. 275(4). 2825–2830. 20 indexed citations

14.

Leconte, Isabelle, Jonathan C. Fox, H. Scott Baldwin, Clayton A. Buck, & Judith L. Swain. (1998). Adenoviral-mediated expression of antisense RNA to fibroblast growth factors disrupts murine vascular development. Developmental Dynamics. 213(4). 421–430. 28 indexed citations

15.

Neschis, David G., et al.. (1998). Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model. Journal of Vascular Surgery. 27(1). 126–134. 29 indexed citations

16.

Kato, Seiya, et al.. (1998). Basic fibroblast growth factor regulates extracellular matrix and contractile protein expression independent of proliferation in vascular smooth muscle cells. In Vitro Cellular & Developmental Biology - Animal. 34(4). 341–346. 11 indexed citations

17.

Fox, Jonathan C., et al.. (1997). Antisense basic fibroblast growth factor gene transfer reduces neointimal thickening after arterial injury. Journal of Vascular Surgery. 25(2). 320–325. 60 indexed citations

18.

Fox, Jonathan C., et al.. (1996). Antisense Inhibition of Basic Fibroblast Growth Factor Induces Apoptosis in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 271(21). 12578–12584. 94 indexed citations

19.

Fox, Jonathan C., et al.. (1994). Myogenic Differentiation Triggered by Antisense Acidic Fibroblast Growth Factor RNA. Molecular and Cellular Biology. 14(6). 4244–4250. 6 indexed citations

20.

Fox, Jonathan C. & Judith L. Swain. (1993). Auto and transactivation of FGF expression: Potential mechanism for regulation of myogenic differentiation. In Vitro Cellular & Developmental Biology - Animal. 29(3). 228–230. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact